Our data indicate that the pharmacological or genetic depletion of RAGE suppresses Ins signaling in BC cells, thus suggesting cell- and tissue-specific mechanisms involved in RAGE-dependent regulation of the IR pathway. The gene discussed is AGER; the disease is breast cancer.